bioMérieux SA (0RUG)
LSE
Closed
Oct 20, 2026
Day's Range
86.6552 wk Range
28.87Overview - 0RUG - bioMérieux SA
Key Statistics
Valuation
Enterprise Value
10.29B
P/E (Trailing)
26.86
Price / Sales (TTM)
2.95
Price / Book
2.84
EV / EBITDA
13.34
Profitability
Profit Margin
10.42%
Operating Margin
15.73%
Return on Assets
7.22%
Return on Equity
9.86%
Ownership
Shares Outstanding
117.69M
Float
42.88M
Held by Insiders
64.28%
Held by Institutions
19.48%
Price stats
Beta
0.16
50-Day Avg
76.06
200-Day Avg
81.26
Dividends
Payout Ratio
26.15%
Frequency
Annual
Market Cap - 0RUG - bioMérieux SA
Peers - 0RUG - bioMérieux SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0RUGLSEbioMérieux SA10.93BMarket Cap-27.03%52-week change26.86P/E (Trailing)10.42%Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.265.80BMarket Cap+20.56%52-week change34.41P/E (Trailing)15.03%Profit Margin
- MTOLSEMitie Group plc262.06BMarket Cap+34.38%52-week change34.77P/E (Trailing)1.47%Profit Margin
- SHCLSEShaftesbury Capital PLC247.70BMarket Cap-4.66%52-week change6.44P/E (Trailing)156.72%Profit Margin
- 0R2BLSEDanaher Corp.154.24BMarket Cap+6.67%52-week change25.48P/E (Trailing)15.94%Profit Margin
- 0HAVLSEAgilent Technologies Inc.54.52BMarket Cap+19.23%52-week change41.54P/E (Trailing)19.53%Profit Margin
- 0JDMLSEIQVIA Holdings Inc.52.94BMarket Cap+21.91%52-week change0.47P/E (Trailing)8.09%Profit Margin
Profile Summary - 0RUG - bioMérieux SA
About
bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
